UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 161 filers reported holding UNIQURE NV in Q3 2019. The put-call ratio across all filers is 0.13 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $64,453,000 | -4.6% | 1,750,000 | +16.7% | 0.92% | -31.4% |
| Q2 2020 | $67,590,000 | -13.7% | 1,500,000 | -9.1% | 1.34% | -49.5% |
| Q1 2020 | $78,293,000 | -35.7% | 1,650,000 | -2.9% | 2.64% | -26.1% |
| Q4 2019 | $121,822,000 | +748.0% | 1,700,000 | +365.8% | 3.58% | +497.2% |
| Q3 2019 | $14,366,000 | +802.4% | 365,000 | +438.7% | 0.60% | +688.2% |
| Q1 2018 | $1,592,000 | -71.1% | 67,758 | -70.1% | 0.08% | -96.4% |
| Q1 2015 | $5,507,000 | – | 226,456 | – | 2.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 841,471 | $15,786,000 | 5.69% |
| Nantahala Capital Management | 2,901,929 | $54,440,000 | 3.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 544,500 | $10,209,000 | 3.27% |
| 683 Capital Management, LLC | 1,373,600 | $25,768,000 | 1.99% |
| PFM Health Sciences, LP | 2,393,311 | $44,899,000 | 1.62% |
| Integral Health Asset Management, LLC | 433,000 | $8,123,000 | 1.58% |
| Privium Fund Management B.V. | 238,998 | $4,283,000 | 1.56% |
| Nantahala Capital Management | 1,000,000 | $18,760,000 | 1.21% |
| Henry James International Management Inc. | 89,469 | $1,678,000 | 0.94% |
| Altium Capital Management LP | 105,000 | $1,970,000 | 0.72% |